This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.
Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.
Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...
Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...
Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.
Medtronic plc added a second U.S. FDA pulsed field ablation (PFA) device approval to its scorecard with the agency’s ...
Introduction Cardiac ablation is a medical procedure for treating arrhythmias (irregular heartbeats). Arrhythmias are electrical irregul ...
Heart ablation involves burning defective heart tissue to improve electrical signaling. Learn who qualifies and more about ...
Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.
Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial ...